decentralized clinical trial

By  Dave Muoio 09:00 am February 24, 2021
Otsuka Pharmaceutical and Click Therapeutics have announced the launch of a new, fully remote clinical trial being conducted on Verily's Project Baseline platform. Called the Mirai study, it will be measuring a digital therapeutics intervention's effectiveness in reducing symptoms of depression among adults who have a major depressive disorder (MDD) diagnosis and are on antidepressant monotherapy...
Community by Current Health is now enrolling participants in a COVID-19 study that uses its FDA-cleared remote monitoring system.
By  Mallory Hackett 11:41 am February 16, 2021
Current Health, a remote patient monitoring platform, has launched Community, its latest initiative to build diverse longitudinal datasets for decentralized clinical trials. Using its FDA-cleared remote monitoring system, Current Health collects hospital-level data such as respiratory rate, heart rate, temperature, oxygen saturation and movement without asking the patient to leave home. The...
Gloved hand with eyedropper and test tubes
By  Mallory Hackett 11:49 am October 20, 2020
On Tuesday, life sciences company LabCorp announced a new technology platform to help streamline the clinical trial and drug development process. The platform was designed for LabCorp’s drug development and decentralized clinical trial business, Covance. It hopes to more easily connect patients to trials, decrease administrative tasks, improve trial resiliency and enhance studies through the use...
By  Dave Muoio 03:35 pm September 17, 2020
The increased adoption of virtual care technologies during the COVID-19 public health emergency is fairly well documented by this point, but a widespread embrace of health technologies is providing a similar upswell on individual niches within the digital health landscape. One such group of beneficiaries are the companies working to develop, validate and distribute digital therapeutics. Speaking...
By  Dave Muoio 02:24 pm July 14, 2020
Decentralized digital therapeutic trial. Pear Therapeutics has enrolled the first participant in the DREAM study, an open-label trial of its Somryst prescription digital therapeutic for chronic insomnia. Conducted as a decentralized trial, the effort will recruit U.S. adults aged 22 to 75 years who have an Insomnia Severity Index score of 8 or higher, as well as at least three months of insomnia...
By  Dave Muoio 03:15 pm May 28, 2020
Clinical lab and drug development giant LabCorp announced this morning a new deal that will streamline its adoption of virtual clinical trials. The company's drug-development-focused contract research organization (CRO), Covance, will use digital clinical trial software-maker Medable's platform to fuel its patient and site interface. This will allow participants easy access to clinical trial apps...